Nionyx Bio

Private

New York City, New YorkHealthcare & Life Scienceshttps://nionyxbio.com/

Last Round

Seed

Sep 29, 2025

Total Funding Raised

$4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nionyx Bio is a biotechnology company that develops AAV-based gene therapies to address kidney genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyAAVadeno-associated viruscapsid engineeringkidney diseasegenetic medicinegene deliverygene cassettebiotech startupdrug discoveryprecision medicinevector libraryrenal therapeuticsbiotech platformgenetic engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nionyx Bio Comps

Public and private peers based on sector, stage, and business model.

Nionyx Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nionyx Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Sep 29, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Magdalena Tyrpien

Co-Founder & CEO

Founding Team

Nionyx Bio Investors

Notable investors and investment history

Nionyx Bio investors
Investor	Rounds
Empire State Development	Seed
Pathway Bioventures	Seed
2048 Ventures	Seed
New York Ventures	Seed
AIN Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 21, 2026
Monthly visitors increased 2859% MoM, reaching 1.4K.
Sep 29, 2025
$4M round led by 2048 Ventures.

View all signals

Nionyx Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Nionyx Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nionyx Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Employee Range6

Year Founded2025

Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.